
My Personal Substack
| Platform | Pricing | Only free issues | Publishes | Twice weekly | |
|---|---|---|---|---|---|
| Issues | 21 | Subscribers | Read | theoncologyshot.com |
Curious about how many subscribers The Oncology Shot with Timothee Olivier has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Recent posts by this newsletter. Browse the email archive.
PATINA was a phase 3 open-label trial testing maintenance palbociclib, in patients with HR+/HER2+ metastatic breast cancer who did not have disease progression after 4 to 8 cycles of first-line chemotherapy plus HER2-targeted treatment.
In a new paper just published in eClinicalMedicine, part of the Lancet group, we discuss, together with , the fascinating consequences of three trials that all studied PARP (Poly (ADP-ribose) Polymerase)-inhibitors (PARPi) in combination wi...
In the Journal of the American Geriatric Society, we recently published, with , a paper describing age differences, over more than 20 years, between patients enrolled in clinical trials and those treated outside clinical trials (full paper ...
The parachute analogy is often used in medicine to argue that studying certain interventions is unethical, comparing them to parachutes, with exceptionnally large effects. However, most medical interventions are far from being parachutes. (...
Other publications recommended by the authors of this newsletter.
The writers behind this newsletter.
Swiss oncologist at Geneva University Hospital. Research on trial methodology, health policy, and critical appraisal. I joined Vinay Prasad’s research lab in November 2021. Geneva Ethics Committee. Co-EiC ESMO Rare Cancers. No COI. Views mine.
Health policy researcher at UCSF
Urologist - robotic surgery
Hans Westgeest (1980) works as medical oncologist in Amphia hospital in Breda, the Netherlands. His expertise is in urogenital oncology and melanoma.
You can find recent issues that have been published by The Oncology Shot with Timothee Olivier on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to The Oncology Shot with Timothee Olivier, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Oncology Shot with Timothee Olivier as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Oncology Shot with Timothee Olivier using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Similar Newsletters to see other publications like The Oncology Shot with Timothee Olivier. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.